Control of severe systemic lupus erythematosus after high-dose immunosuppressive therapy and transplantation of CD34+ purified autologous stem cells from peripheral blood

Lupus

Volumn 8, Issue 4, 1999, Pages 320-323

  Fouillard, L ^a   Gorin, N C ^a   Laporte, J Ph ^a   Leon, A ^a   Brantus, J F ^b   Miossec, P ^b  

^a HÔPITAL SAINT ANTOINE   (France)

^b EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

Autologous stem cell transplantation; Severe systemic lupus erythematosus

Indexed keywords

ANTINUCLEAR ANTIBODY; CARMUSTINE; CD34 ANTIGEN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYTARABINE; ERYTHROPOIETIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOSUPPRESSIVE AGENT; MELPHALAN;

ADULT; ARTHRALGIA; ARTICLE; CASE REPORT; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; MUCOSA INFLAMMATION; MYALGIA; PRIORITY JOURNAL; REMISSION; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; VISUAL IMPAIRMENT;

ADULT; ANTIGENS, CD34; B-LYMPHOCYTES; CYCLOPHOSPHAMIDE; ERYTHROPOIETIN; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MOUTH MUCOSA; STOMATITIS; T-LYMPHOCYTES; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 0033044823     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/096120399678847894     Document Type: Article

References (8)

1. Ikehara S. Bone marrow transplantation for autoimmune diseases Acta Haematol 1998; 99: 116-132.
2. Marmont AM. Perspective immune ablation with stem-cell rescue: a possible cure for systemic lupus erythematosus? Lupus 1993; 2: 151-156.
3. Euler HH, Marmoud AM, Baugalupo A et al Early recurrence of persistence of autoimmune diseases after unmanipulated autologous stem cell transplantation Blood 1996; 88: 3621-3625.
4. Tyndall A, Gratwohl A. Blood and marrow stem cell transplants in autoimmune disease: a consensus report written on behalf of the European League Against Rheumatism (EULAR) and the European Group for Blood and Marrow Transplantation (EBMT). Br J Rheumatol 1997; 36: 390-392.
5. Marmont AM, Van Lint MT, Gualandi F, Bacigalupo A. Case report: Autologous marrow stem cell transplantation for severe systemic lupus erythematosus of long duration. Lupus 1997, 6: 545-548.
6. Burt RK, Traynor A, Pope R et al Treatment of autoimmune disease by intense immunosuppressive conditioning and autologous hematopoietic stem cell transplantation. Blood 1998; 92: 3505-3514.
7. Marmont AM. New horizons m the treatment of autoimmune disease: stem cell transplantation. Ann Rev Med in press.
8. Snowden JA, Biggs JC, Milliker ST et al. A randomised, blinded, placebo-controlled, dose escalation study of the tolerability and efficacy of filgrastim for haemopoietic stem cell mobilisation in patients with severe active rheumatoid arthritis. Bone Marrow Trans 1998; 22: 1035-1041